corenews
Mar 17, 2026

Cancer Doctor Weighs In On Biden's Diagnosis, How Much Longer He Might Live

As questions swirl around President Joe Biden’s health following the announcement of his prostate cancer diagnosis, national media outlets quickly turned to one of the country’s leading specialists to help describe what the diagnosis means — and what comes next.

Dr. Geoffrey Sonn, a urologic oncologist at Stanford University with extensive experience treating prostate and kidney cancers, has emerged as a key medical voice weighing in on the president’s condition. Sonn has spoken to several major outlets in recent days, offering a sober but reassuring explanation of how advanced prostate cancer is typically managed and why the diagnosis, while serious, is not necessarily a near-term death sentence.

Professional headshot of Geoffrey Sonn, MD, urologic oncologist at Stanford, Photo Credit: Geoffrey A. Sonn, MD/X

Professional headshot of Geoffrey Sonn, MD, urologic oncologist at Stanford, Photo Credit: Geoffrey A. Sonn, MD/X

One of the most important distinctions Sonn emphasized is that metastatic prostate cancer, while not considered curable, is often controllable for extended periods of time. In interviews with outlets including Politico and The Los Angeles Times, Sonn pointed to major advances over the past decade that have transformed patient outcomes. New generations of hormone-based medications, he explained, can significantly slow the disease’s progression and allow patients to live productive lives for years.

Other posts